Evaluation of vestibular biopsy features in patients affected by fibromyalgia, by vulvodynia or by their association.

OBJECTIVE To evaluate the histologic features of vestibular biopsies from patients affected by fibro myalgia (FM), or vulvodynia (VD), or the their association (FM-VD) in order to facilitate differential diagnosis among conditions that present sexual pain with similar clinical characteristics. STUDY DESIGN Fourty-four women already diagnosed with FM were recruited to evaluate the presence of sexual pain not owing to FM. Fourteen women affected by sexual pain of unknown origin who came to our department requesting treatment were also recruited. All subjects were interviewed regarding their history of pain and examined in order to exclude vaginal conditions. Sexual pain did not show the characteristics of VD in 18 FM women; in the remaining 22 women VD resulted as associated with FM. All fourteen self-referred women were diagnosed with VD. All subjects underwent a posterior vestibular biopsy at the fourchette under local anesthesia. Tissue specimens were processed for histologic examination and immunostained for S-100protein and CD34. Statistical analysis was performed with the Pearson's Chisquare test. RESULTS Data analysis showed a statistically significant prevalence of inflammation in the VD group. Analysis of the histologic features showed that the concomitant presence of inflammation, nerve bundles, and fibrosis (often mild) is prevalent in VD. Fibrosis is highly frequent and often moderate/severe in FM and it is rarely associated to inflammation and nerve bundles. FM-VD women show intermediate grading. CONCLUSIONS Our findings show different histologic characteristics in vestibular biopsy in patients affected by Fibro Myalgia, by Vulvodynia or by their association that could be useful to facilitate the differential diagnosis between conditions of sexual pain with similar clinical characteristics.

[1]  A. Rapkin,et al.  Vulvodynia: The Role of Inflammation in the Etiology of Localized Provoked Pain of the Vulvar Vestibule (Vestibulodynia) , 2015, Seminars in Reproductive Medicine.

[2]  C. Beham‐Schmid,et al.  Mast cell infiltrates in vulvodynia represent secondary and idiopathic mast cell hyperplasias , 2015, Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS).

[3]  S. Meri,et al.  Activation of vestibule-associated lymphoid tissue in localized provoked vulvodynia. , 2015, American journal of obstetrics and gynecology.

[4]  M. Iadarola,et al.  Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia-afflicted and pain-free women , 2015, Pain.

[5]  T. Morgan,et al.  CD4-Positive T-Cell Recruitment in Primary-Provoked Localized Vulvodynia: Potential Insights into Disease Triggers , 2014, Journal of lower genital tract disease.

[6]  Ananda Sen,et al.  Relationship Between Vulvodynia and Chronic Comorbid Pain Conditions , 2012, Obstetrics and gynecology.

[7]  N. Bohm-Starke,et al.  Medical and physical predictors of localized provoked vulvodynia , 2010, Acta obstetricia et gynecologica Scandinavica.

[8]  S. Regauer,et al.  Diagnosis and management of vulvodynia should include biopsy and histological examination , 2010, The British journal of dermatology.

[9]  Hong Li,et al.  Histologic and receptor analysis of primary and secondary vestibulodynia and controls: a prospective study. , 2010, American journal of obstetrics and gynecology.

[10]  D. Clauw Fibromyalgia: an overview. , 2009, The American journal of medicine.

[11]  David A. Williams,et al.  Understanding fibromyalgia: lessons from the broader pain research community. , 2009, The journal of pain : official journal of the American Pain Society.

[12]  Leonid Kalichman Association between fibromyalgia and sexual dysfunction in women , 2009, Clinical Rheumatology.

[13]  S. Florell,et al.  The role of vulvar skin biopsy in the evaluation of chronic vulvar pain. , 2008, American journal of obstetrics and gynecology.

[14]  G. Bachmann,et al.  Assessment of vulvodynia symptoms in a sample of US women: a prevalence survey with a nested case control study. , 2007, American journal of obstetrics and gynecology.

[15]  G. Bachmann,et al.  Vulvodynia: Characteristics and Associations With Comorbidities and Quality of Life , 2006, Obstetrics and gynecology.

[16]  H. Haefner,et al.  Vulvodynia: strategies for treatment. , 2005, Clinical obstetrics and gynecology.

[17]  I. Ben‐Ami,et al.  The Major Histopathologic Characteristics in the Vulvar Vestibulitis Syndrome , 2005, Gynecologic and Obstetric Investigation.

[18]  J. Bornstein,et al.  Hyperinnervation and Mast Cell Activation May Be Used as Histopathologic Diagnostic Criteria for Vulvar Vestibulitis , 2004, Gynecologic and Obstetric Investigation.

[19]  G. Terenghi,et al.  Increased innervation of the vulval vestibule in patients with vulvodynia , 2003, The British journal of dermatology.

[20]  W. Ledger,et al.  Defective regulation of the proinflammatory immune response in women with vulvar vestibulitis syndrome. , 2002, American journal of obstetrics and gynecology.

[21]  M. Hilliges,et al.  The expression of cyclooxygenase 2 and inducible nitric oxide synthase indicates no active inflammation in vulvar vestibulitis , 2001, Acta obstetricia et gynecologica Scandinavica.